Can C-11 Acetate PET Be a Feasible Option for Assessing Non-Culprit Lesion in STEMI Patients?
作者信息
Kong Eunjung
机构信息
Department of Nuclear Medicine, Yeungnam University Medical School and Hospital, Daegu, Korea.
出版信息
J Cardiovasc Imaging. 2022 Jul;30(3):181-184. doi: 10.4250/jcvi.2022.0040.
Abstract
摘要
相似文献
1
Can C-11 Acetate PET Be a Feasible Option for Assessing Non-Culprit Lesion in STEMI Patients?碳-11 醋酸盐正电子发射断层扫描能否成为评估 ST 段抬高型心肌梗死患者非罪犯病变的可行选择？
J Cardiovasc Imaging. 2022 Jul;30(3):181-184. doi: 10.4250/jcvi.2022.0040.
2
Culprit Lesion Morphology on Optical Coherence Tomography in ST-elevation Myocardial Infarction vs Non ST-elevation Myocardial Infarction - A Systematic Review of 7526 Patients.ST段抬高型心肌梗死与非ST段抬高型心肌梗死光学相干断层扫描的罪犯病变形态学——对7526例患者的系统评价
J Saudi Heart Assoc. 2023 Mar 9;35(1):40-49. doi: 10.37616/2212-5043.1329. eCollection 2023.
3
Treating patients with non-STEMI: stent the culprit artery only or address all lesions?
Curr Treat Options Cardiovasc Med. 2008 Feb;10(1):93-7. doi: 10.1007/s11936-008-0010-4.
4
Vessel fractional flow reserve-based non-culprit lesion reclassification in patients with ST-segment elevation myocardial infarction: Impact on treatment strategy and clinical outcome (FAST STEMI I study).基于血管 Fractional Flow Reserve 的 ST 段抬高型心肌梗死患者罪犯病变再分类：对治疗策略和临床结局的影响（FAST STEMI I 研究）。
Int J Cardiol. 2023 Feb 15;373:33-38. doi: 10.1016/j.ijcard.2022.11.043. Epub 2022 Nov 25.
5
Increased Vulnerability and Distinct Layered Phenotype at Culprit and Nonculprit Lesions in STEMI Versus NSTEMI.STEMI 与 NSTEMI 罪犯病变与非罪犯病变的易损性增加和明显的分层表型。
JACC Cardiovasc Imaging. 2022 Apr;15(4):672-681. doi: 10.1016/j.jcmg.2021.07.022. Epub 2021 Sep 15.
6
Localising culprit artery in inferior STEMI.定位下壁 ST 段抬高型心肌梗死罪犯血管。
Open Heart. 2023 Jan;10(1). doi: 10.1136/openhrt-2022-002093.
7
Culprit Lesion Coronary Intervention Before Complete Angiography in ST-Elevation Myocardial Infarction: A Randomized Clinical Trial.罪犯病变经皮冠状动脉介入治疗在 ST 段抬高型心肌梗死完全血管造影前：一项随机临床试验。
JAMA Netw Open. 2024 Mar 4;7(3):e243729. doi: 10.1001/jamanetworkopen.2024.3729.
8
Complete Revascularization vs Culprit Lesion-Only Percutaneous Coronary Intervention for Angina-Related Quality of Life in Patients With ST-Segment Elevation Myocardial Infarction: Results From the COMPLETE Randomized Clinical Trial.ST 段抬高型心肌梗死患者心绞痛相关生活质量的完全血运重建与罪犯病变血运重建的经皮冠状动脉介入治疗比较：来自 COMPLETE 随机临床试验的结果。
JAMA Cardiol. 2022 Nov 1;7(11):1091-1099. doi: 10.1001/jamacardio.2022.3032.
9
Detection of culprit coronary lesion location in pre-hospital 12-lead ECG.院前12导联心电图中罪犯冠状动脉病变位置的检测。
J Electrocardiol. 2014 Nov-Dec;47(6):890-4. doi: 10.1016/j.jelectrocard.2014.07.014. Epub 2014 Jul 31.
10
Clinical and angiographic characteristics of out-of-hospital cardiac arrest among patients with ST-segment elevation myocardial infarction.ST 段抬高型心肌梗死患者院外心脏骤停的临床和血管造影特征。
Arch Cardiovasc Dis. 2024 Feb;117(2):153-159. doi: 10.1016/j.acvd.2023.12.005. Epub 2024 Jan 9.
本文引用的文献
1
Evaluation of Non-infarct-Related Arteries Using C-11 Acetate PET in STEMI With Multivessel Disease.使用C-11乙酸PET对多支血管病变的ST段抬高型心肌梗死患者的非梗死相关动脉进行评估。
J Cardiovasc Imaging. 2022 Jul;30(3):169-180. doi: 10.4250/jcvi.2021.0189.
2
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2021 ACC/AHA/SCAI 冠状动脉血运重建指南：美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
J Am Coll Cardiol. 2022 Jan 18;79(2):e21-e129. doi: 10.1016/j.jacc.2021.09.006. Epub 2021 Dec 9.
3
Complete Revascularization with Multivessel PCI for Myocardial Infarction.多支血管 PCI 治疗心肌梗死的完全血运重建。
N Engl J Med. 2019 Oct 10;381(15):1411-1421. doi: 10.1056/NEJMoa1907775. Epub 2019 Sep 1.
4
Diagnostic Accuracy of Computed Tomography-Derived Fractional Flow Reserve : A Systematic Review.基于 CT 的血流储备分数的诊断准确性：系统评价。
JAMA Cardiol. 2017 Jul 1;2(7):803-810. doi: 10.1001/jamacardio.2017.1314.
5
Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction.心肌梗死的血流储备分数指导下的多血管血管成形术。
N Engl J Med. 2017 Mar 30;376(13):1234-1244. doi: 10.1056/NEJMoa1701067. Epub 2017 Mar 18.
6
Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial.完全血运重建与罪犯病变治疗在 ST 段抬高型心肌梗死和多血管病变患者中的比较（DANAMI-3—PRIMULTI）：一项开放标签、随机对照试验。
Lancet. 2015 Aug 15;386(9994):665-71. doi: 10.1016/s0140-6736(15)60648-1.
7
Coronary vasomotor function in infarcted and remote myocardium after primary percutaneous coronary intervention.直接经皮冠状动脉介入治疗后梗死心肌和远隔心肌的冠状动脉血管舒缩功能
Heart. 2015 Oct;101(19):1577-83. doi: 10.1136/heartjnl-2015-307825. Epub 2015 Aug 5.
8
Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial.急性ST段抬高型心肌梗死合并多支血管病变患者行直接经皮冠状动脉介入治疗时完全血运重建与仅对罪犯病变血运重建的随机试验：CvLPRIT试验
J Am Coll Cardiol. 2015 Mar 17;65(10):963-72. doi: 10.1016/j.jacc.2014.12.038.
9
Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning.心肌保护的分子基础：缺血预处理、后处理和远程处理中的信号转导。
Circ Res. 2015 Feb 13;116(4):674-99. doi: 10.1161/CIRCRESAHA.116.305348.
10
Randomized trial of preventive angioplasty in myocardial infarction.随机对照试验预防心肌梗死的血管成形术。
N Engl J Med. 2013 Sep 19;369(12):1115-23. doi: 10.1056/NEJMoa1305520. Epub 2013 Sep 1.
Zotero 插件